Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Preferred Shares: 2017-2025

Historic Preferred Shares for Fortress Biotech (FBIO) over the last 8 years, with Sep 2025 value amounting to $3,000.

  • Fortress Biotech's Preferred Shares changed negligibly% to $3,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Fortress Biotech's Preferred Shares amounted to $3,000 in Q3 2025, which was down 0.00% from $3,000 recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Preferred Shares peaked at $3,000 during Q1 2021, and registered a low of $3,000 during Q1 2021.
  • Moreover, its 3-year median value for Preferred Shares was $3,000 (2025), whereas its average is $3,000.
  • Data for Fortress Biotech's Preferred Shares shows a peak YoY spiked of 50.00% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Fortress Biotech's Preferred Shares stood at $3,000 in 2021, then remained steady at $3,000 in 2022, then remained steady at $3,000 in 2023, then remained steady at $3,000 in 2024, then remained steady at $3,000 in 2025.
  • Its Preferred Shares was $3,000 in Q3 2025, compared to $3,000 in Q2 2025 and $3,000 in Q1 2025.